CTOs on the Move

Renovia Incorporated

www.renoviainc.com

 
Renovia was formed to develop and commercialize products for better first-line diagnosis and treatment to improve the condition-specific quality of life for millions of women with pelvic floor disorders. Renovia`s technology enables treatment via precise visualization of pelvic movement in real-time during pelvic floor muscle training, while monitoring usage and progress over time. As a women`s health organization, Renovia is in pursuit of scalable and cost-effective care for pelvic floor disorders delivered through the power of digital health.
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Funding

Renovia Incorporated raised $17M on 04/19/2021

Similar Companies

Interrad Medical

Interrad Medical is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CanadaDrugs.com LP

CanadaDrugs.com LP is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

OrthoHelix Surgical Designs

OrthoHelix Surgical Designs is a Medina, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Novera Drugs

Novera Drugs is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Invendo Medical

Invendo Medical aims to become a globally leading developer and distributor of disposable, highly flexible and easy-to-use endoscopy products in the field of gastroenterology. Innovation activity in gastroenterological endoscopy has in the past decades nearly exclusively focused on the improvement of optical capabilities. However, invendo medical´s goal is to improve patient compliance and thereby increase the number of procedures performed. In order to achieve its goal the company first focussed on an application in the diagnosis and treatment of colorectal cancers (CRC). CRC is the second leading cause of cancer death with an estimated annual worldwide death toll of 510,000 people. More than 1 million new cases are diagnosed every year. However 90-100% of colorectal cancers can be avoided if diagnosed early on